Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "mgt"


8 mentions found


A handful of stocks are entering or about to enter the worrisome so-called death cross. A death cross can also be indicative of a forthcoming bear market pattern. Intel Intel disappointed Wall Street's first-quarter expectations last week, when it posted a beat in earnings per share but came up light in revenue. McDonald's McDonald's has also drawn a death cross. CVS Health Unlike the other two names, CVS Health is nearing a death cross.
Persons: Wall Street's, Goldman Sachs, Toshiya Hari, McDonald's, Kevin Caliendo, Caliendo Organizations: Intel, CNBC, Intel Intel, Nvidia, CVS Health, CVS, UBS Locations: Gaza, mgt
We always use this code: garbage in, garbage out," Raphael, chief data officer and Goldman partner, told Business Insider. As Goldman goes all-in on AI, Raphael is emerging as a key player impacting the bank's future. How Raphael's data platform team is leading the way for AI innovation at GoldmanEven though Raphael's day can vary greatly, it always starts the same. AdvertisementOne is the data platform team, which oversees the entire data stack, including infrastructure and how people access data. For Goldman, AI is not new.
Persons: Goldman Sachs, Raphael, Goldman, It's, SecDB, That's Organizations: Service, Business, Goldman, JPMorgan, UC Berkeley, Engineering SWAT, Curation
Investors should buy Bausch Health Companies as shares can more than double from here, Jefferies said. Bausch Health is embroiled in a legal battle over Xifaxan, its drug for irritable bowel syndrome with diarrhea, to prevent generics from entering the market. Bausch Health has been hoping to spin off its valuable vision care unit, Bausch + Lomb, for several years. Bausch Health shares are higher this year by more than 22%. The analyst cited other reasons why Bausch Health shares will get a boost.
Persons: Jefferies, Glen, mgt, Santangelo, Bausch, — CNBC's Michael Bloom Organizations: Health Companies, Health, Bausch Health, FDA Locations: Xifaxan, Norwich, Bausch, New Jersey
Investors should snap up shares of beaten-down regional bank Western Alliance, according to Wells Fargo. The firm reiterated its overweight rating on the stock, while lowering its price target to $65 from $90. Still, the new price target implies 148.9% upside from the stock's Monday closing price of $26.12. Western Alliance shares declined 47% on Monday as part of a massive selloff of regional bank stocks following the failures of SVB Financial and Signature Bank. Western Alliance shares were up 18.2% during premarket trading on Tuesday.
Wells Fargo reiterates PNC as overweight Wells said PNC should benefit from a "flight to quality." Deutsche Bank reiterates Charles Schwab as buy Deutsche said liquidity risks for Charles Schwab are overblown. Wells Fargo reiterates Western Alliance Bancorp as overweight Wells said it's standing by shares of the regional bank. Wells Fargo reiterates American Express as overweight Wells said investors should buy the dip in American Express shares. Bank of America reiterates Amazon as buy Bank of America said it's standing by its buy rating on shares of Amazon.
Morgan Stanley upgrades Sarepta to overweight from equal weight Morgan Stanley said it's bullish on the company's gene therapy drug, SRP-9001. Morgan Stanley reiterates Rivian as overweight Morgan Stanley said it's standing by its overweight rating on the EV maker after its earnings report on Tuesday, but says it's now a show-me story. Morgan Stanley reiterates Eli Lilly as top pick Morgan Stanley said the stock is best-in-class and that it's bullish on its diabetes drug, Mounjaro. Morgan Stanley names JD.com a catalyst driven idea Morgan Stanley said it's bullish heading into the China e-commerce company's earnings on March 9. Morgan Stanley reiterates Microsoft as overweight Morgan Stanley said it's standing by shares of Microsoft.
Organizations: ~$
Lyft shares fell more than 30% during Friday premarket trading as traders weighed a weaker-than-expected forecast from the ridesharing company in its most recent earnings report. LYFT 1D mountain Lyft shares tumble For market observers on Wall Street, that was hardly a good enough explanation. As of Thursday's close, Lyft shares jumped more than 47%, following a 74% drop in 2022. While the analyst did not have a price target available, his previous target in January was $24 for the stock. Lastly, Loop Capital's Rob Sanderson downgraded Lyft to hold from buy, and dropped the price target to $10 from $17.
Jefferies on Monday upgraded Las Vegas Sands and Wynn Resorts after Macao announced its plan to allow Chinese tour groups back in the casinos as soon as November. "The moment we've been waiting for," Jefferies analysts led by David Katz said in a note to clients Monday. Shares of Wynn Resorts rallied 14% Monday, while Las Vegas Sands also soared a similar amount. Jefferies also lifted the price target for Las Vegas Sands to $50 from $40, Wynn to $75 from $62. Still, the analysts raised the question about the concession renewal process following the reopening.
Total: 8